Coordinated Action of miR-146a and Parkin Gene Regulate Rotenone-induced Neurodegeneration

Abhishek Jauhari1,2,3, Tanisha Singh1,3, Saumya Mishra1,2

  • 1Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Lucknow 226001, Uttar Pradesh, India.

Insights

Parkinson's disease involves mitochondrial issues. This study reveals how NF-κβ activation upregulates miR-146a, downregulating Parkin protein, impairing mitophagy, and worsening neurodegeneration.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Mitochondrial dysfunction is central to neurodegenerative diseases like Parkinson's.
  • Efficient removal of damaged mitochondria (mitophagy) is crucial for neuronal health.

Purpose of the Study:

  • To investigate the role of microRNA-146a (miR-146a) in rotenone-induced Parkinson's disease model.
  • To elucidate the mechanism linking nuclear factor kappa beta (NF-κβ), miR-146a, and Parkin in neurodegeneration.

Main Methods:

  • Utilized a systemic rotenone exposure model in rats to induce Parkinson's-like pathology.
  • Performed global microRNA profiling to identify differentially expressed miRNAs.
  • Investigated the binding of NF-κβ to the miR-146a gene promoter and its effect on Parkin protein levels.

Main Results:

  • Rotenone exposure upregulated miR-146a, a known inflammation regulator.
  • Activated NF-κβ was found to bind the miR-146a promoter, increasing its transcription.
  • This led to decreased Parkin protein, inhibiting mitophagy and increasing reactive oxygen species.

Conclusions:

  • Identified a novel NF-κβ-miR-146a pathway contributing to Parkinson's disease pathogenesis.
  • This pathway impairs mitophagy by downregulating Parkin, leading to mitochondrial accumulation and neurodegeneration.